How to buy West Pharmaceutical Services shares

Own West Pharmaceutical Services shares in just a few minutes.

West Pharmaceutical Services logo

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

West Pharmaceutical Services, Inc (WST) is a leading medical instruments & supplies business with stocks listed in the US. It opened the day at US$357.2 after a previous close of US$357.59. During the day the price has varied from a low of USD356.54 to a high of USD361.04. The latest price was USD360.09 (25 minute delay). West Pharmaceutical Services is listed on the NYSE. All prices are listed in US Dollars.

How to buy shares in West Pharmaceutical Services

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for West Pharmaceutical Services. Find the share by name or ticker symbol: WST. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until West Pharmaceutical Services reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$333.43, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of West Pharmaceutical Services, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of West Pharmaceutical Services. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

West Pharmaceutical Services share price

Use our graph to track the performance of WST stocks over time.

West Pharmaceutical Services shares at a glance

Information last updated 2021-06-22.
OpenUS$357.2
HighUS$361.04
LowUS$356.54
CloseUS$360.09
Previous closeUS$357.59
Change US$2.5
Change % 0.6991%
Volume 230,797
Information last updated 2021-06-17.
52-week rangeUS$212.2757 - US$352.99
50-day moving average US$334.6637
200-day moving average US$299.1073
Target priceUS$351.6
PE ratio 73.3665
Dividend yield US$0.66 (0.19%)
Earnings per share (TTM) US$5.5764

Compare share trading platforms to buy stock

Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro (US, EU stock trading)
US$0
US$10 per month if there’s been no login for 12 months
0.50%
Global shares, US shares, ETFs
Zero brokerage share trading on US stocks with trades as low as $50.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
US$0
$50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
US$9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
US$0
No
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy West Pharmaceutical Services stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

West Pharmaceutical Services price performance over time

Historical closes compared with the last close of $360.09

1 week (2021-06-16) 4.04%
1 month (2021-05-21) 7.99%
3 months (2021-03-23) 27.13%
6 months (2020-12-23) 27.95%
1 year (2020-06-23) 65.53%
2 years (2019-06-21) 195.06%
3 years (2018-06-22) 256.56%
5 years (2016-06-23) 375.30%

Is West Pharmaceutical Services under- or over-valued?

Valuing West Pharmaceutical Services stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of West Pharmaceutical Services's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

West Pharmaceutical Services's P/E ratio

West Pharmaceutical Services's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 73x. In other words, West Pharmaceutical Services shares trade at around 73x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

West Pharmaceutical Services's PEG ratio

West Pharmaceutical Services's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4793. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into West Pharmaceutical Services's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

West Pharmaceutical Services's EBITDA

West Pharmaceutical Services's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$626.2 million.

The EBITDA is a measure of a West Pharmaceutical Services's overall financial performance and is widely used to measure a its profitability.

West Pharmaceutical Services financials

Revenue TTM US$2.3 billion
Operating margin TTM 22.1%
Gross profit TTM US$767.8 million
Return on assets TTM 12.89%
Return on equity TTM 2549.41%
Profit margin 18.19%
Book value 24.783
Market capitalisation US$25.5 billion

TTM: trailing 12 months

Shorting West Pharmaceutical Services shares

There are currently 1.0 million West Pharmaceutical Services shares held short by investors – that's known as West Pharmaceutical Services's "short interest". This figure is 17.4% up from 862,890 last month.

There are a few different ways that this level of interest in shorting West Pharmaceutical Services shares can be evaluated.

West Pharmaceutical Services's "short interest ratio" (SIR)

West Pharmaceutical Services's "short interest ratio" (SIR) is the quantity of West Pharmaceutical Services shares currently shorted divided by the average quantity of West Pharmaceutical Services shares traded daily (recently around 450342.66666667). West Pharmaceutical Services's SIR currently stands at 2.25. In other words for every 100,000 West Pharmaceutical Services shares traded daily on the market, roughly 2250 shares are currently held short.

However West Pharmaceutical Services's short interest can also be evaluated against the total number of West Pharmaceutical Services shares, or, against the total number of tradable West Pharmaceutical Services shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case West Pharmaceutical Services's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 West Pharmaceutical Services shares in existence, roughly 10 shares are currently held short) or 0.0138% of the tradable shares (for every 100,000 tradable West Pharmaceutical Services shares, roughly 14 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against West Pharmaceutical Services.

Find out more about how you can short West Pharmaceutical Services stock.

West Pharmaceutical Services share dividends

12%

Dividend payout ratio: 11.57% of net profits

Recently West Pharmaceutical Services has paid out, on average, around 11.57% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.2% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), West Pharmaceutical Services shareholders could enjoy a 0.2% return on their shares, in the form of dividend payments. In West Pharmaceutical Services's case, that would currently equate to about $0.66 per share.

While West Pharmaceutical Services's payout ratio might seem low, this can signify that West Pharmaceutical Services is investing more in its future growth.

West Pharmaceutical Services's most recent dividend payout was on 3 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 19 July 2021 (the "ex-dividend date").

Have West Pharmaceutical Services's shares ever split?

West Pharmaceutical Services's shares were split on a 2:1 basis on 26 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your West Pharmaceutical Services shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for West Pharmaceutical Services shares which in turn could have impacted West Pharmaceutical Services's share price.

West Pharmaceutical Services share price volatility

Over the last 12 months, West Pharmaceutical Services's shares have ranged in value from as little as US$212.2757 up to US$352.99. A popular way to gauge a stock's volatility is its "beta".

WST.US volatility(beta: 0.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while West Pharmaceutical Services's is 0.9875. This would suggest that West Pharmaceutical Services's shares are less volatile than average (for this exchange).

West Pharmaceutical Services overview

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform